If Carl Woodbridge is going to sell his entire holding, that's going to keep the share price depressed for quite some time. But I think patience will pay off with this one.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025